Progenics Pharmaceuticals, Inc. License Agreements
9 Contracts & Agreements
- License Agreement, dated April 28, 2016, between PSMA Development Company LLC and Bayer AS (Filed With SEC on May 4, 2016)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 11, 2016)
- LICENSE AGREEMENT This agreement ("Agreement") is made by and between University of Zurich Ramistrasse 71 CH-8006Zurich(Switzerland) (,UniversityofZurich") and... (Filed With SEC on March 13, 2014)
- LICENSE GREEMENT (Filed With SEC on May 10, 2013)
- 2010 AGREEMENT RELATED TO PROGENICSs MNTX IN-LICENSE (Filed With SEC on May 10, 2011)
- PARTIALTERMINATION AND LICENSE AGREEMENT (Filed With SEC on March 13, 2009)
- AMENDED AND RESTATED PSMA/PSMP LICENSE AGREEMENT by and among PROGENICS PHARMACEUTICALS, INC., CYTOGEN CORPORATION and PSMA DEVELOPMENT COMPANY LLC Dated April 20, 2006 (Filed With SEC on August 8, 2006)
- EXHIBIT 10.27 OPTION AND LICENSE AGREEMENT (Filed With SEC on March 15, 2006)
- LICENSE AND CO-DEVELOPMENT AGREEMENT by and among WYETH, acting through its WYETH PHARMACEUTICALS DIVISION, WYETH-WHITEHALL PHARMACEUTICALS, INC., WYETH-AYERST LEDERLE, INC., and... (Filed With SEC on March 15, 2006)
